Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes (Q37109702)

18 August 2017

Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes (English)

1 reference

adaptive radiation therapy

18 August 2017

0 references

0 references

Lei Deng

5

0 references

Nicholas G Zaorsky

object named as

Nicholas G Zaorsky

2

0 references

author name string

Huan-Huan Wang

1

1 reference

18 August 2017

Mao-Bin Meng

3

1 reference

18 August 2017

Xian-Liang Zeng

4

1 reference

18 August 2017

Yong-Chun Song

6

1 reference

18 August 2017

Hong-Qing Zhuang

7

1 reference

18 August 2017

Feng-Tong Li

8

1 reference

18 August 2017

Lu-Jun Zhao

9

1 reference

18 August 2017

Zhi-Yong Yuan

10

1 reference

18 August 2017

Ping Wang

11

1 reference

18 August 2017

Xi-Shan Hao

12

1 reference

18 August 2017

language of work or name

English

0 references

publication date

23 February 2016

1 reference

18 August 2017

1 reference

18 August 2017

7

1 reference

18 August 2017

14

1 reference

18 August 2017

18135-18145

1 reference

What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Radical irradiation of extracranial oligometastases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiotherapy for oligometastases.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

The role of local therapy in the management of lung and liver oligometastases.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiation therapy for inoperable early stage lung cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiation therapy in multiple organ sites

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

The oligometastatic state - separating truth from wishful thinking

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Regional lymph node classification for lung cancer staging

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4951277

A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques

4 December 2018

1 reference

12 December 2020

Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol

1 reference

12 December 2020

Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study

1 reference

12 December 2020

Central-airway necrosis after stereotactic body-radiation therapy

1 reference

12 December 2020

Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience

1 reference

12 December 2020

Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy

1 reference

12 December 2020

Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy

1 reference

12 December 2020

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience

1 reference

12 December 2020

Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer

1 reference

12 December 2020

Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases

1 reference

12 December 2020

Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation

1 reference

12 December 2020

Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group

1 reference

12 December 2020

Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastases

1 reference

12 December 2020

Identifiers

DOI

10.18632/ONCOTARGET.7636

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

26919113

1 reference